Drug intelligence / Profile preview

Pic-D3

Development stage: Unknown
Lead developer: Healthon Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Pic-D3 is a branded generic formulation of cholecalciferol (Vitamin D3) marketed by Healthon Lifesciences, an Indian pharmaceutical company. Cholecalciferol is a fat-soluble vitamin that serves as a precursor to the active hormone calcitriol. It functions by binding to and activating the Vitamin D receptor (VDR) in the intestines, kidneys, and bones, thereby increasing the efficiency of intestinal calcium and phosphorus absorption. This process is critical for maintaining serum calcium levels and supporting bone mineralization. Pic-D3 is primarily indicated for the prevention and treatment of Vitamin D deficiency, as well as an adjunct in the management of osteoporosis and osteomalacia.

Brand names: Pic-D3Pic-D-3Pic-D 3
Other names: Vitamin D3cholecalciferol

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Pic-D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pic-D3.

Explore the full profile